Evaluation of real-world mobility in age-related macular degeneration

被引：0
|
作者：
Sabyasachi Sengupta
Angeline M Nguyen
Suzanne W van Landingham
Sharon D Solomon
Diana V Do
Luigi Ferrucci
David S Friedman
Pradeep Y Ramulu
机构：
[1] Johns Hopkins University,Wilmer Eye Institute
[2] University of Nebraska Medical Center,Truhlsen Eye Institute
[3] National Institute on Aging,The Longitudinal Studies Section, Clinical Research Branch
[4] National Institutes of Health,Dana Center for Preventive Ophthalmology
[5] Johns Hopkins Bloomberg School of Public Health,undefined
[6] Johns Hopkins University,undefined
来源：
BMC Ophthalmology | / 15卷
关键词：
Age-related macular degeneration; Physical activity; Mobility;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Neovascular age-related macular degeneration: A review of findings from the real-world Fight Retinal Blindness! registry
    Nguyen, Vuong
    Barthelmes, Daniel
    Gillies, Mark C.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 49 (07): : 652 - 663
  • [42] FREQUENCY OF RANIBIZUMAB INJECTIONS FOR THE TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION: CANADIAN REAL-WORLD UTILIZATION DATA
    Davies, B.
    Gonder, J.
    Blouin, J.
    Zaour, N.
    VALUE IN HEALTH, 2012, 15 (07) : A575 - A575
  • [43] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Hoseok Yeom
    Hye Ji Kwon
    Yoon Jeon Kim
    Junyeop Lee
    Young Hee Yoon
    Joo Yong Lee
    Scientific Reports, 13
  • [44] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [45] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Zarbin, Marco A.
    MacCumber, Mathew W.
    Karcher, Helene
    Adiguzel, Eser
    Mayhook, Andrew
    LaPrise, Andrew
    Bilano, Ver L.
    Igwe, Franklin
    Ip, Michael S.
    Wykoff, Charles C.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1357 - 1368
  • [46] Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
    Jern, Irene
    Forsell, Sara
    Norberg, Helena
    BMJ OPEN, 2022, 12 (09):
  • [47] Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration
    Yeom, Hoseok
    Kwon, Hye Ji
    Kim, Yoon Jeon
    Lee, Junyeop
    Yoon, Young Hee
    Lee, Joo Yong
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [48] Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study
    Touma-Falci, Liane
    Moreira-Neto, Carlos Augusto
    Taleb, Alexandre Chater
    Prieto, Marcela Bach
    Packer, Thais
    Oliveira, Julio Cesar Barbour
    Birck, Marina Gabriela
    Julian, Guilherme Silva
    Forestiero, Francisco Jose
    BMC OPHTHALMOLOGY, 2021, 21 (01)
  • [49] The impact of treatment intensity over 3 years of real-world data of neovascular age-related macular degeneration
    Gkorou, Olga
    Duncan, Holly
    Hogg, Jeffry
    Stone, Lydia
    Blyth, Michelle
    Brandes, Lesley
    Devenport, Adele
    Timms, Leanne
    Talks, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [50] Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study
    Liane Touma-Falci
    Carlos Augusto Moreira-Neto
    Alexandre Chater Taleb
    Marcela Bach Prieto
    Thais Packer
    Julio Cesar Barbour Oliveira
    Marina Gabriela Birck
    Guilherme Silva Julian
    Francisco Jose Forestiero
    BMC Ophthalmology, 21
12345